Hedgehog-interacting protein orchestrates alveologenesis and protects against bronchopulmonary dysplasia and emphysema
Science Advances · 2025
DOI: 10.1126/sciadv.adu2958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Datian Ye und 10 weiteren Autor:innen. Beteiligte Einrichtung: Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Carrier Proteins, Pulmonary Alveoli, Pulmonary Emphysema. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Most of the lung’s gas-exchange surface forms during alveologenesis and its disruption causes bronchopulmonary dysplasia (BPD) in infants, characterized by alveolar simplification and myofibroblast accumulation. BPD also increases the risk of adult emphysema, marked by alveolar loss. Despite this connection, mechanisms linking these conditions and effective treatments are still lacking. We identify hedgehog-interacting protein ( HHIP ), associated with both BPD and emphysema, as a critical regulator of alveologenesis. During this process, Hhip -expressing cells expanded, accompanied by hedgehog (Hh) signaling inhibition and myofibroblast transition. Stromal-specific Hhip deletion led to hyperactivation of Hh-IGF1 signaling axis, causing persistent SMA + myofibroblasts and epithelial stem/progenitor cell senescence. Hyperactivation of this pathway was also observed in human BPD and hyperoxia-induced BPD models. Early Hhip deficiency resulted in adult emphysema with myofibroblast accumulation. We developed a therapeutic Fc-fused HHIP protein that mitigated BPD in neonatal mice and prevented adult emphysema. These findings establish HHIP as a critical regulator of alveologenesis and a therapeutic target for BPD and emphysema.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
- Perfect Life Science Research Institute, Perfect (GuangDong) Co. Ltd., Zhongshan 528402, China.
- School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
- State Key Laboratory of Molecular Development Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China.
- Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
ORCID-Profile: Datian Ye, Shiyun Feng, Xinguo Yang, Jing Zhang, Haixin Feng, Minqi Zhou, Bin Zhou, Tien Peng, Chaoqun Wang
Förderung
- NHLBI NIH HHS
Zitieren
APA
Ye, D., Feng, S., Yang, X., Su, Y., Zhang, J., Feng, H., Zhou, M., Zhou, B., Duan, L., Peng, T., & Wang, C. (2025). Hedgehog-interacting protein orchestrates alveologenesis and protects against bronchopulmonary dysplasia and emphysema. Science Advances. https://doi.org/10.1126/sciadv.adu2958
Vancouver
Ye D, Feng S, Yang X, Su Y, Zhang J, Feng H, et al. Hedgehog-interacting protein orchestrates alveologenesis and protects against bronchopulmonary dysplasia and emphysema. Science Advances. 2025. doi:10.1126/sciadv.adu2958
BibTeX
@article{Ye2025,
author = {Ye, Datian and Feng, Shiyun and Yang, Xinguo and Su, Yanjing and Zhang, Jing and Feng, Haixin and Zhou, Minqi and Zhou, Bin and Duan, Lihui and Peng, Tien and Wang, Chaoqun},
title = {Hedgehog-interacting protein orchestrates alveologenesis and protects against bronchopulmonary dysplasia and emphysema},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adu2958}
}
EUVIMED